Background: Previous studies have investigated the sustained aberrantly activated Interleukin-6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) signaling pathway is crucial for pancreatic cancer growth and metastasis. Suppressor of cytokine signaling 3 (SOCS3), as a key negative feedback regulator of this signaling pathway, is usually down-regulated in various cancers. In the present study, we aim at exploring the biological function and the underlying molecular regulation mechanisms of SOCS3 in pancreatic cancer. Methods: The expression of SOCS3 and other genes in pancreatic cancer was examined by Quantitative real-time PCR, western blotting and immunohistochemical staining. The interaction between pSTAT3 and DNA Methyltransferase 1 (DNMT1) was investigated by co-immunoprecipitation assay. Luciferase reporter assay was used to investigate the transcriptional regulation of pSTAT3 and DNMT1 on the SOCS3 gene. The effects of SOCS3 on the biological behavior of pancreatic cancer cells were assessed both in vitro and vivo. Furthermore, we performed a comprehensive analysis of the expression of SOCS3 in a pancreatic cancer tissue microarray (TMA) and correlated our findings with pathological parameters and outcomes of the patients. Results: We showed that SOCS3 expression was decreased in phosphorylated STAT3 (pSTAT3)-positive tumors and was negatively correlated with pSTAT3 in pancreatic cancer cells. We also found that IL-6/STAT3 promoted SOCS3 promoter hypermethylation by increasing DNMT1 activity; silencing DNMT1 or 5-aza-2-deoxycytidine (5-AZA) treatment could reverse the down-regulation of SOCS3 mediated by IL-6. Using co-immunoprecipitation and luciferase reporter assays, we found that STAT3 recruited DNMT1 to the promoter region of SOCS3 and inhibited its transcriptional activity. Overexpression of SOCS3 significantly inhibited cell proliferation, which may be due to the increase in G1-S phase arrest; overexpression of SOCS3 also inhibited cell migration and invasion as well as tumorigenicity in nude mice. Pancreatic cancer tissue microarray analysis showed that high SOCS3 expression was a good prognostic factor and negatively correlated with tumor volume and metastasis. Conclusion: We demonstrated that activated IL-6/STAT3 signaling could induce SOCS3 methylation via DNMT1, which led to pancreatic cancer growth and metastasis. These data also provided a mechanistic link between sustained aberrantly activated IL-6/STAT3 signaling and SOCS3 down-regulation in pancreatic cancer. Thus, inhibitors of STAT3 or DNMT1 may become novel strategies for treating pancreatic cancer.
Background: The colonoscopy withdrawal time (WT) and adenoma detection rate (ADR) are widely used quality indicators for colonoscopy. However, no study has investigated the appropriate colonoscopy WTs of individual colonic segments that will allow trainees to achieve a higher ADR. Thus, we analyzed for the first time the relationship between colonoscopy WT and the ADR/polyp detection rate (PDR) in the proximal, left-sided and entire colon among trainees. Methods: This retrospective study involved 611 consecutive patients who underwent colonoscopy from March 2018 to March 2019 performed by 6 trainees in the Endoscopy Center of Shanghai General Hospital. The WTs for the individual colonic segments and any significant findings of colonoscopies were retrospectively retrieved from the trainees’ records and verified in the endoscopy center database. ADR/PDR was defined as the number of colonoscopies detecting at least 1 polyp/adenoma divided by the total number of colonoscopies. Comparisons of PDR and ADR between the 2 groups were conducted using chi-square test. Multilevel analysis was performed to consider individual differences among the 6 trainees. Multilevel binary logistic regression analysis was performed to analyze the factors that influenced the PDR, ADR and advanced adenoma detection rate (AADR) for the entire colon, and trainee status was included as a random effect. Results: The mean WTs were 4.20±1.09, 4.27±1.12, and 8.48±1.87 minutes for the proximal, left-sided, and entire colon, respectively. A longer WT [odds ratio (OR) 1.499, 95% confidence interval (CI): 1.381–1.628, P<0.001; OR 1.409, 95% CI: 1.265–1.569, P<0.001, respectively] was significantly associated with a higher PDR and ADR. The PDR (P<0.001) and ADR (P4 minutes than when the WT was ≤4 minutes in both the proximal and left-sided colon, while the PDR (P<0.001) and ADR (P8 minutes in the entire colon. Conclusions: In order to improve trainee colonoscopy performance, trainees were recommended to have WTs of at least 4 minutes in the proximal colon, 4 minutes in the left-sided colon and 8 minutes in the entire colon during negative screening colonoscopies.
22 August 2023 in Scandinavian Journal of Gastroenterology
ObjectivesRetinol binding protein (RBP) is associated with an increased risk of insulin resistance, metabolic syndrome, atherosclerosis and hypertension. This study aimed to evaluate serum RBP levels in patients with acute pancreatitis (AP).MethodsThe study included 1,871 AP patients, including 1,411 with mild AP (MAP), 244 with moderately severe AP (MSAP), and 186 with severe AP (SAP). Retrospective analysis was conducted on RBP concentrations and other clinical data of AP patients.ResultsAP patients were subgrouped by RBP level into low RBP (LRBP), normal RBP (NRBP), and high RBP (HRBP) groups. The LRBP group showed a significantly higher proportion of SAP patients than NRBP and HRBP groups. Additionally, the LRBP group had the highest BISAP and CTSI scores among the three groups; WBC and CRP levels in the NRBP group were significantly lower than those in the LRBP and HRBP groups. RBP was better at predicting acute necrotic collection (ANC) than other local complications, with an area under the curve (AUC) of 0.821. RBP was also an independent risk factor for acute lung injury (ALI) and ANC in AP patients. The AUC of RBP for predicting ALI was 0.829, with 30.45 mg/L as the optimal cutoff value, and the sensitivity and specificity were 59.70% and 96.50%, respectively. The AUC of RBP for predicting ANC was 0.821, with 28.35 mg/L as the optimal cutoff value, and the sensitivity and specificity were 61.20% and 95.50%, respectively.ConclusionsSerum RBP had predictive value for AP severity, local and systemic complications.